InvestorsHub Logo

mcbio

12/11/10 5:18 PM

#110760 RE: rkrw #110758

Yes, partnering in asia. You can't exactly break up indications by cancer type.

Ok thanks.

I would recommend listening to a few recent conference calls to get up to speed.

I think we've covered all of the major topics here, at least the main ones I am interested in. Thanks very much to you and the others that have chimed in. Lots of good discussion, as always here. I'm quite anxious to see the rida results in 1Q11 to see if I will be taking a position in ARIA for the first time.

genisi

12/12/10 8:41 AM

#110773 RE: rkrw #110758

Any sense on this agent from Deciphera? I see that Dr. Moshe Talpaz is one of the principal Investigators.

http://clinicaltrials.gov/ct2/show/NCT00827138